Pollen Allergy Market Size 2023 to 2033 | By Alcon, bioMerieux SA, HOB Biotech, Quest Diagnostics, Stallergenes Greer

The global Pollen Allergy market is expected to be valued US$ 5850.8 million in 2023, with a CAGR of 4.2%. As a result of technological advances in healthcare, the market is expected to reach US$ 8828.6 million by 2033.

The rising number of people suffering from pollen-based allergies, such as hay fever, is driving market expansion. Furthermore, as the number of sufferers, particularly youngsters, expands, so does the global Pollen Allergy market. Rapid urbanisation in emerging economies would be a prominent factor driving the growth of the Pollen Allergy market during the forecast period.

Request a report sample to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16236

Increased greenhouse gas emissions may create pollen-induced reparative sickness, slowing the expansion of the Pollen Allergy sector.

In terms of revenue share, corticosteroids dominated the Pollen Allergy market, and their use as a first-line treatment is expected to contribute to market expansion.

North America has dominated the global Pollen Allergy market due to the increasing frequency of allergies and awareness of therapy. The Pollen Allergy market in Europe is expected to be the world’s second largest. Increased disease awareness among folks is another key factor that could boost market expansion in this region.

Key Takeaways from the Market Study

• The Pollen Allergy market was worth US$ 5850.8 million in 2023.
• The Pollen Allergy industry is expected to grow at a 4.2% CAGR between 2023 and 2033.
• The Pollen Allergy market is expected to be worth US$ 8828.6 million by 2033.
• Corticosteroids dominated the Pollen Allergy market in 2023, accounting for 35.5% of total revenue.
• Pollen allergies are expected to increase at a 3.8% CAGR in China by 2033.

“Technological advancement in healthcare and increase in the prevalence of allergic rhinitis and rise in the number of patients especially children suffering from pollen allergies expected to radically transform the Pollen Allergy market in the coming years,” comments an analyst at FMI.

For critical insights on this market, ask an expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-16236

Competitive Landscape

Some of the leading manufacturers and players assessed in the global Pollen Allergy market are bioMerieux SA, HOB Biotech Group Corp Ltd, Alcon, HYCOR Biomedical, Inc, Immunomic Therapeutics, Quest Diagnostics Incorporated, Omega Diagnostics Group PLC, Siemens Healthcare Private Limited, Stallergenes Greer, Lincoln Diagnostics, Inc. and others

Manufacturers and players functional in the global Pollen Allergy market are adopting various corporate growth strategies such as new product launches, mergers and acquisitions, and geographical expansion, among others.

• Stallergenes Greer, a worldwide healthcare corporation specialising in allergen immunotherapy (AIT), said today that its EfficAPSI real-world study showed encouraging results in the summer of 2022. The real-world study, which was presented at the 2022 European Academy of Allergy and Clinical Immunology (EAACI) congress in Prague (Czech Republic), confirmed that sublingual liquid allergen immunotherapy (AIT) has a significant benefit on the onset and worsening of asthma in patients with allergic rhinitis.
• Lincoln Diagnostics offers a painless option for skin allergy testing with the Multi-Test PC (pain control). This test offers high sensitivity, specificity, and low variability in results while being virtually painless.

More insights available

The North American region has a significant Pollen Allergies market share due to the high prevalence of allergies, favorable reimbursement policies, and the presence of key market players. The European region also has a substantial market share due to the growing prevalence of allergies, high healthcare spending, and increasing awareness about the available treatment options.

For in-depth competitive analysis, Buy Now@ https://www.futuremarketinsights.com/checkout/16236

Key Segments Covered in the Pollen Allergy Industry Survey

Pollen Allergy Market by Product Type:

• Instruments
• Consumables
• Services

Pollen Allergy Market by Allergen Type:

• Food
• Inhaled
• Drug
• Other

Pollen Allergy Market by Therapeutics Drug class:

• Antihistamines
• Decongestants
• Corticosteroids
• Mast Cell Stabilizers
• Leukotriene Inhibitors
• Nasal Anticholinergics
• Immunomodulators
• Auto injectable Epinephrine
• Immunotherapy

Pollen Allergy Market by End-User:

• Diagnostic Laboratories
• Hospitals

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs